Manufacturing Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing Pharmaceutical TechnologyWhen Eli Lilly's Lebanon campus is complete, it will manufacture several of the pharma's APIs and genetic medicines to serve US patients.Read full story pharminent May 7, 2026 (Last updated: May 8, 2026) Pharmaceutical Technology When Eli Lilly’s Lebanon campus is complete, it will manufacture several of the pharma’s APIs and genetic medicines to serve US patients. Read full story Post navigation Previous: Daiichi Sankyo and Waiv partner for ADC biomarkersNext: UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies Related Stories Manufacturing BMS banks on Texas for $2.3bn multi-modal manufacturing facility pharminent August 11, 2026 Manufacturing AsymBio to secure $184m to support growth in biologics manufacturing pharminent August 5, 2026 Manufacturing Lilly and Resilience invest $750M in diabetes and obesity drug device supply pharminent July 31, 2026
